Department of Physiology, Temple University School of Medicine, Philadelphia, PA, USA.
Neuroscience. 2010 Dec 15;171(3):852-8. doi: 10.1016/j.neuroscience.2010.09.029. Epub 2010 Sep 24.
Although hypertension has been implicated in the pathogenesis of vascular disease, its role in inflammatory responses, especially in brain, remains unclear. In this study we found key mechanisms by which angiotensin II (AngII) mediates cerebral microvascular inflammation. C57BL/6 male mice were subjected to slow-pressor dose of AngII infusion using osmotic mini-pumps at a rate of 400 ng/kg/min for 14 days. Vascular inflammation in the brain was evaluated by analysis of leukocyte-endothelial interaction and blood-brain barrier (BBB) permeability. Results from intravital microscopy of pial vessels in vivo, revealed a 4.2 fold (P<0.05, compared to vehicle) increase in leukocyte adhesion on day 4 of AngII infusion. This effect persisted through day 14 of AngII infusion, which resulted in a 2.6 fold (P<0.01, compared to vehicle) increase in leukocyte adhesion. Furthermore, evaluation of BBB permeability by Evans Blue extravasation showed that Ang II significantly affected the BBB, inducing 3.8 times (P<0.05, compared to vehicle) higher permeability. Previously we reported that AngII mediated hypertension promotes oxidative stress in the vasculature. Thus, we used the superoxide scavenger; 4-hydroxy-TEMPO (Tempol) to determine whether AngII via oxidative stress could contribute to higher leukocyte adhesion and increased BBB permeability. Tempol was given via drinking water (2 mmol) on day 4th following Ang II infusion, since oxidative stress increases in this model on day 4. Treatment with Tempol significantly attenuated the increased leukocyte/endothelial interactions and protected the BBB integrity on day 14 of AngII infusion. In conclusion, AngII via oxidative stress increases cerebral microvasculature inflammation and leads to greater immune-endothelial interaction and higher BBB permeability. This finding may open new avenues for the management of nervous system pathology involving cerebrovascular inflammation.
尽管高血压与血管疾病的发病机制有关,但它在炎症反应中的作用,尤其是在大脑中的作用仍不清楚。在这项研究中,我们发现了血管紧张素 II (AngII) 介导脑微血管炎症的关键机制。C57BL/6 雄性小鼠通过渗透压微型泵以 400ng/kg/min 的速度输注 AngII 进行缓慢升压,持续 14 天。通过分析白细胞-内皮相互作用和血脑屏障 (BBB) 通透性来评估大脑中的血管炎症。体内软脑膜血管的活体显微镜检查结果显示,在 AngII 输注的第 4 天,白细胞黏附增加了 4.2 倍(与载体相比,P<0.05)。这种效应持续到 AngII 输注的第 14 天,导致白细胞黏附增加了 2.6 倍(与载体相比,P<0.01)。此外,通过 Evans Blue 外渗评估 BBB 通透性表明,Ang II 显著影响 BBB,诱导通透性增加 3.8 倍(与载体相比,P<0.05)。之前我们报道过,AngII 介导的高血压会促进血管中的氧化应激。因此,我们使用超氧化物清除剂 4-羟基-TEMPO(Tempol)来确定 AngII 是否通过氧化应激导致更高的白细胞黏附和增加的 BBB 通透性。Tempol 通过 Ang II 输注后第 4 天的饮用水(2mmol)给予,因为该模型中的氧化应激在第 4 天增加。Tempol 治疗显著减弱了 AngII 输注第 14 天白细胞/内皮相互作用的增加,并保护 BBB 的完整性。总之,AngII 通过氧化应激增加大脑微血管炎症,导致更强的免疫-内皮相互作用和更高的 BBB 通透性。这一发现可能为涉及脑血管炎症的神经系统病理的治疗开辟新途径。